Stockreport

Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF CARMIEL, Israel, Sept. 4, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production an [Read more]